4//SEC Filing
Moran Kyle 4
Accession 0000950170-24-110141
CIK 0001631574other
Filed
Sep 26, 8:00 PM ET
Accepted
Sep 27, 8:00 PM ET
Size
5.1 KB
Accession
0000950170-24-110141
Insider Transaction Report
Form 4
Moran Kyle
Chief Financial Officer
Transactions
- Sale
Ordinary Shares
2024-09-25$9.00/sh−17,146$154,314→ 19,777 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2023.
- [F2]Includes 3,002 ordinary shares acquired on July 14, 2024, under the issuer's 2019 Employee Share Purchase Plan.
Documents
Issuer
Wave Life Sciences Ltd.
CIK 0001631574
Entity typeother
Related Parties
1- filerCIK 0001657765
Filing Metadata
- Form type
- 4
- Filed
- Sep 26, 8:00 PM ET
- Accepted
- Sep 27, 8:00 PM ET
- Size
- 5.1 KB